Heparin-induced thrombocytopenia: clinical presentations and therapeutic management.
Publication
, Journal Article
Larned, ZL; O'Shea, SI; Ortel, TL
Published in: Clin Adv Hematol Oncol
June 2003
With increasing indications for heparin usage, an understanding of heparin-induced thrombocytopenia (HIT) as a complication of heparin therapy is more essential than ever. Complications of HIT can result in significant morbidity and mortality. We review the clinical presentations of HIT, laboratory and diagnostic workup, and treatment agents available or being evaluated.
Duke Scholars
Published In
Clin Adv Hematol Oncol
ISSN
1543-0790
Publication Date
June 2003
Volume
1
Issue
6
Start / End Page
356 / 364
Location
United States
Related Subject Headings
- Treatment Outcome
- Thrombocytopenia
- Oncology & Carcinogenesis
- Humans
- Heparin
- Disease Management
- Comorbidity
- Anticoagulants
Citation
APA
Chicago
ICMJE
MLA
NLM
Larned, Z. L., O’Shea, S. I., & Ortel, T. L. (2003). Heparin-induced thrombocytopenia: clinical presentations and therapeutic management. Clin Adv Hematol Oncol, 1(6), 356–364.
Larned, Zoë L., Susan I. O’Shea, and Thomas L. Ortel. “Heparin-induced thrombocytopenia: clinical presentations and therapeutic management.” Clin Adv Hematol Oncol 1, no. 6 (June 2003): 356–64.
Larned ZL, O’Shea SI, Ortel TL. Heparin-induced thrombocytopenia: clinical presentations and therapeutic management. Clin Adv Hematol Oncol. 2003 Jun;1(6):356–64.
Larned, Zoë L., et al. “Heparin-induced thrombocytopenia: clinical presentations and therapeutic management.” Clin Adv Hematol Oncol, vol. 1, no. 6, June 2003, pp. 356–64.
Larned ZL, O’Shea SI, Ortel TL. Heparin-induced thrombocytopenia: clinical presentations and therapeutic management. Clin Adv Hematol Oncol. 2003 Jun;1(6):356–364.
Published In
Clin Adv Hematol Oncol
ISSN
1543-0790
Publication Date
June 2003
Volume
1
Issue
6
Start / End Page
356 / 364
Location
United States
Related Subject Headings
- Treatment Outcome
- Thrombocytopenia
- Oncology & Carcinogenesis
- Humans
- Heparin
- Disease Management
- Comorbidity
- Anticoagulants